ClariTrial | Search Clinical Trials

Explore/Prostate Cancer

Status

Phase

8,738 results for “Prostate Cancer”

Page 1 of 583

Completed

Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer

Phase 1Phase 2Prostate Cancer

CV787 (CG7870)

Cell Genesys

Compare CT.gov Full analysis →

Suspended

Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate Cancer

Phase 3Prostate Cancer

Radical retropubic prostatectomyExternal beam radiotherapy

University of Rome Tor Vergata500 participantsCompletes Sep 2001

Compare CT.gov Full analysis →

Completed

Results posted

Optimizing Veteran-Centered Prostate Cancer Survivorship Care

N/AProstate Cancer

Interactive Voice Response Symptom ManagementTailored Newsletters

VA Office of Research and Development556 participants4 sites · United StatesCompletes Feb 2018

Compare CT.gov Full analysis →

Completed

Early Assessment of Treatment Response Using Functional Diffusion Mapping

N/AProstate Cancer

Diffusion MRI

University of Michigan Rogel Cancer Center20 participants1 site · United StatesCompletes Oct 2012

Compare CT.gov Full analysis →

Completed

Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase 1Recurrent Prostate CancerStage IV Prostate CancerUnspecified Adult Solid Tumor, Protocol Specific

tanespimycindocetaxel

National Cancer Institute (NCI)80 participants1 site · United StatesCompletes Jan 2008

Compare CT.gov Full analysis →

UNKNOWN

a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without Biopsy

N/AProstatic NeoplasmsProstatectomyProstate Biopsy

Fudan University71 participantsCompletes Dec 2024

Compare CT.gov Full analysis →

Recruiting

Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer

N/AColon PolypColorectal CarcinomaLocalized Prostate Carcinoma

Aerobic ExerciseBiopsy ProcedureBiospecimen Collection+6 more

City of Hope Medical Center30 participants2 sites · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Active

A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer

N/AProstate Cancer

Standard of Care IMRT (Photon)Standard of Care Proton TherapyProton Arm 1: Standard Proton Therapy+1 more

University of Florida3,000 participants53 sites · United StatesCompletes Feb 2026

Compare CT.gov Full analysis →

Completed

Prospective Evaluation of 68-Ga-prostate Specific Membrane Antigen (PSMA)-Positron Emission Tomograph (PET) and Early Prostatic Specific Antigen (PSA) Kinetics During Salvage Radiotherapy for Personalizing the Management of Men With Relapse of Prostate Cancer After Radical Prostatectomy

N/ARelapsed Prostate Cancer

External radiation therapy

Lund University Hospital100 participants1 site · SwedenCompletes Dec 2019

Compare CT.gov Full analysis →

Completed

Urine Proteome of Surgical Patients and Healthy Volunteers

N/ARenal Cell Cancer

Washington University School of Medicine664 participants1 site · United StatesCompletes Jul 2016

Compare CT.gov Full analysis →

Not Yet Recruiting

Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer（mCRPC）

Early Phase 1Prostate Cancer

[177Lu]Lu-PSMA-137

Peking University First Hospital12 participantsCompletes Mar 2025

Compare CT.gov Full analysis →

Recruiting

Comprehensive Outcomes for After Cancer Health

N/AOvarian CancerBreast CancerLung Cancer

Digital Health Coaching ProgramFitbit

Pack Health625 participants7 sites · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Terminated

Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection

N/ACancer

Augmented Whole-body Scanning via Magnifying PETPET/CT

Washington University School of Medicine11 participants1 site · United StatesCompletes Mar 2026

Compare CT.gov Full analysis →

Terminated

Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors

Phase 2Solid Tumor

AtezolizumabRucaparib

Gustave Roussy, Cancer Campus, Grand Paris130 participants1 site · FranceCompletes Jan 2023

Compare CT.gov Full analysis →

Terminated

A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)

Phase 1Phase 2Prostate CancerBreast CancerOvarian Cancer

Docetaxel plus lonafarnib

Merck Sharp & Dohme LLC5 participantsCompletes Dec 2009

Compare CT.gov Full analysis →

1–15 of 8,738

Explore/Prostate Cancer

Status

Phase

8,738 results for “Prostate Cancer”

Page 1 of 583

Completed

Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer

Phase 1Phase 2Prostate Cancer

CV787 (CG7870)

Cell Genesys

Compare CT.gov Full analysis →

Suspended

Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate Cancer

Phase 3Prostate Cancer

Radical retropubic prostatectomyExternal beam radiotherapy

University of Rome Tor Vergata500 participantsCompletes Sep 2001

Compare CT.gov Full analysis →

Completed

Results posted

Optimizing Veteran-Centered Prostate Cancer Survivorship Care

N/AProstate Cancer

Interactive Voice Response Symptom ManagementTailored Newsletters

VA Office of Research and Development556 participants4 sites · United StatesCompletes Feb 2018

Compare CT.gov Full analysis →

Completed

Early Assessment of Treatment Response Using Functional Diffusion Mapping

N/AProstate Cancer

Diffusion MRI

University of Michigan Rogel Cancer Center20 participants1 site · United StatesCompletes Oct 2012

Compare CT.gov Full analysis →

Completed

Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase 1Recurrent Prostate CancerStage IV Prostate CancerUnspecified Adult Solid Tumor, Protocol Specific

tanespimycindocetaxel

National Cancer Institute (NCI)80 participants1 site · United StatesCompletes Jan 2008

Compare CT.gov Full analysis →

UNKNOWN

a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without Biopsy

N/AProstatic NeoplasmsProstatectomyProstate Biopsy

Fudan University71 participantsCompletes Dec 2024

Compare CT.gov Full analysis →

Recruiting

Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer

N/AColon PolypColorectal CarcinomaLocalized Prostate Carcinoma

Aerobic ExerciseBiopsy ProcedureBiospecimen Collection+6 more

City of Hope Medical Center30 participants2 sites · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Active

A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer

N/AProstate Cancer

Standard of Care IMRT (Photon)Standard of Care Proton TherapyProton Arm 1: Standard Proton Therapy+1 more

University of Florida3,000 participants53 sites · United StatesCompletes Feb 2026

Compare CT.gov Full analysis →

Completed

N/ARelapsed Prostate Cancer

External radiation therapy

Lund University Hospital100 participants1 site · SwedenCompletes Dec 2019

Compare CT.gov Full analysis →

Completed

Urine Proteome of Surgical Patients and Healthy Volunteers

N/ARenal Cell Cancer

Washington University School of Medicine664 participants1 site · United StatesCompletes Jul 2016

Compare CT.gov Full analysis →

Not Yet Recruiting

Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer（mCRPC）

Early Phase 1Prostate Cancer

[177Lu]Lu-PSMA-137

Peking University First Hospital12 participantsCompletes Mar 2025

Compare CT.gov Full analysis →

Recruiting

Comprehensive Outcomes for After Cancer Health

N/AOvarian CancerBreast CancerLung Cancer

Digital Health Coaching ProgramFitbit

Pack Health625 participants7 sites · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Terminated

Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection

N/ACancer

Augmented Whole-body Scanning via Magnifying PETPET/CT

Washington University School of Medicine11 participants1 site · United StatesCompletes Mar 2026

Compare CT.gov Full analysis →

Terminated

Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors

Phase 2Solid Tumor

AtezolizumabRucaparib

Gustave Roussy, Cancer Campus, Grand Paris130 participants1 site · FranceCompletes Jan 2023

Compare CT.gov Full analysis →

Terminated

A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)

Phase 1Phase 2Prostate CancerBreast CancerOvarian Cancer

Docetaxel plus lonafarnib

Merck Sharp & Dohme LLC5 participantsCompletes Dec 2009

Compare CT.gov Full analysis →

1–15 of 8,738